Stockscreener 앱 받기
2.4435
0.41%
-0.0065
전일 마감가:
$2.45
열려 있는:
$2.46
하루 거래량:
950.63K
Relative Volume:
0.10
시가총액:
$2.31B
수익:
$1.31M
순이익/손실:
$-597.65M
주가수익비율:
-2.5191
EPS:
-0.97
순현금흐름:
$-425.62M
1주 성능:
-2.79%
1개월 성능:
-10.62%
6개월 성능:
-2.79%
1년 성능:
-31.27%
1일 변동 폭
$2.42
$2.47
1주일 범위
$2.40
$2.67
52주 변동 폭
$1.83
$7.48
Immunitybio Inc Stock (IBRX) Company Profile
명칭
Immunitybio Inc
전화
(844) 696-5235
주소
3530 JOHN HOPKINS COURT, SAN DIEGO
IBRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.4401 | 2.32B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.16 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
475.87 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.75 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
839.57 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.12 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | 개시 | H.C. Wainwright | Buy |
| 2025-01-10 | 개시 | BTIG Research | Buy |
| 2023-05-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | 개시 | Jefferies | Buy |
Immunitybio Inc 주식(IBRX)의 최신 뉴스
Applying big data sentiment scoring on ImmunityBio Inc.Trade Signal Summary & Entry Point Strategy Guides - newser.com
Why ImmunityBio Inc. (26CA) stock benefits from AI revolutionTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-10-20 12:10:55 - newser.com
ImmunityBio Inc. stock trend outlook and recovery pathLong Setup & Free Growth Oriented Trading Recommendations - newser.com
Why ImmunityBio Inc. (26CA) stock is a strong analyst pickShare Buyback & Community Consensus Trade Alerts - newser.com
Tick level data insight on ImmunityBio Inc. volatilityQuarterly Trade Report & Precise Buy Zone Tips - newser.com
Will ImmunityBio Inc. stock outperform tech sector in 2025Market Sentiment Report & Technical Entry and Exit Alerts - nchmf.gov.vn
Short interest data insights for ImmunityBio Inc.Trade Entry Report & Fast Moving Trade Plans - newser.com
Is ImmunityBio Inc. stock a buy on dipsWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Will ImmunityBio Inc. stock split again soon2025 Trading Volume Trends & Technical Entry and Exit Tips - nchmf.gov.vn
How ImmunityBio Inc. stock reacts to job market data2025 Market Trends & Weekly Market Pulse Alerts - nchmf.gov.vn
Can machine learning forecast ImmunityBio Inc. recovery2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Institution Moves: Will ImmunityBio Inc. stock outperform tech sector in 20252025 Support & Resistance & Stepwise Swing Trade Plans - nchmf.gov.vn
Discover ImmunityBio And Two Other Growth Stocks With High Insider Ownership - simplywall.st
Is ImmunityBio Inc a good long term investmentResistance Breakout Alerts & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Will ImmunityBio Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
Will ImmunityBio Inc. rebound enough to break evenBear Alert & Community Consensus Picks - newser.com
How to recover losses in ImmunityBio Inc. stockJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Published on: 2025-10-11 12:10:43 - earlytimes.in
ImmunityBio, Inc.Common Stock (NQ: IBRX - FinancialContent
Why Immunitybio Inc. (IBRX) Soared on Thursday - MSN
ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - MSN
ImmunityBio, Inc. (26CA.F) stock price, news, quote and history - Yahoo
Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews
IBRX stockholders via consent approve 1.65B common share authorization - Stock Titan
Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
ImmunityBio Inc. stock retracement – recovery analysis2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
ANKTIVA Reimbursement Gains and UK Approval Might Change The Case For Investing In ImmunityBio (IBRX) - Sahm
ImmunityBio, Inc. (NASDAQ:IBRX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView
ImmunityBio: A Small Bet Is Warranted (NASDAQ:IBRX) - Seeking Alpha
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Immunitybio Inc (IBRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.33%
2.54%
자본화:
|
볼륨(24시간):